These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27223158)

  • 41. Treatments for osteoporosis - looking beyond the HORIZON.
    Compston J
    N Engl J Med; 2007 May; 356(18):1878-80. PubMed ID: 17476015
    [No Abstract]   [Full Text] [Related]  

  • 42. Yearly zoledronic acid in postmenopausal osteoporosis.
    de Nijs RN; Westgeest AA
    N Engl J Med; 2007 Aug; 357(7):711; author reply 714-5. PubMed ID: 17699824
    [No Abstract]   [Full Text] [Related]  

  • 43. Yearly zoledronic acid in postmenopausal osteoporosis.
    Chang JT
    N Engl J Med; 2007 Aug; 357(7):713-4; author reply 714-5. PubMed ID: 17703528
    [No Abstract]   [Full Text] [Related]  

  • 44. [Expert group consensus: prevention, diagnosis and treatment of bone loss and osteoporosis in postmenopausal breast cancer patients after aromatase inhibitor therapy].
    Xiu Bing-He ;
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):876-9. PubMed ID: 24447490
    [No Abstract]   [Full Text] [Related]  

  • 45. Denosumab, osteoporosis, and prevention of fractures.
    Blackwood J
    N Engl J Med; 2009 Nov; 361(22):2189; author reply 2190-1. PubMed ID: 19950411
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of osteoporosis in an active female patient?].
    Fassbender WJ
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2416. PubMed ID: 18988136
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of Osteoporosis.
    Cotts KG; Cifu AS
    JAMA; 2018 Mar; 319(10):1040-1041. PubMed ID: 29536084
    [No Abstract]   [Full Text] [Related]  

  • 48. Compliance with treatment for osteoporosis.
    Cooper A
    Lancet; 2006 Nov; 368(9548):1648. PubMed ID: 17098078
    [No Abstract]   [Full Text] [Related]  

  • 49. Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis.
    Migliore A; Broccoli S; Massafra U; Cassol M; Frediani B
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):658-67. PubMed ID: 23543450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Teriparatide for glucocorticoid-induced osteoporosis.
    Diez-Perez A; Sole E
    J Rheumatol; 2012 Mar; 39(3):461-2. PubMed ID: 22383352
    [No Abstract]   [Full Text] [Related]  

  • 51. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2014 Sep; 56(1452):91-6. PubMed ID: 25247344
    [No Abstract]   [Full Text] [Related]  

  • 52. A once-yearly IV bisphosphonate for osteoporosis.
    Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
    [No Abstract]   [Full Text] [Related]  

  • 53. Drugs for postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2011 Nov; 9(111):67-74. PubMed ID: 22033166
    [No Abstract]   [Full Text] [Related]  

  • 54. Alendronate in postmenopausal osteoporosis.
    McGrath H
    N Engl J Med; 1996 Mar; 334(11):734; author reply 734-5. PubMed ID: 8594443
    [No Abstract]   [Full Text] [Related]  

  • 55. Bisphosphonates and glucocorticoids: effects on bone quality.
    Lems WF
    Arthritis Rheum; 2007 Nov; 56(11):3518-22. PubMed ID: 17968935
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment holidays in patients with postmenopausal osteoporosis: whom and when?
    Reyes García R; García Martín A; Muñoz-Torres M
    Endocrinol Nutr; 2012 Dec; 59(10):573-4. PubMed ID: 23031434
    [No Abstract]   [Full Text] [Related]  

  • 57. Bridging the gap between evidence and practice in osteoporosis.
    Hansen LB
    Am J Health Syst Pharm; 2008 Feb; 65(4):297. PubMed ID: 18238766
    [No Abstract]   [Full Text] [Related]  

  • 58. Yearly zoledronic acid in postmenopausal osteoporosis.
    Poole KE; Kaptoge S; Reeve J
    N Engl J Med; 2007 Aug; 357(7):711-2; author reply 714-5. PubMed ID: 17703530
    [No Abstract]   [Full Text] [Related]  

  • 59. Low rates of treatment in postmenopausal women with a history of low trauma fractures: results of audit in a Fracture Liaison Service.
    Premaor MO; Pilbrow L; Tonkin C; Adams M; Parker RA; Compston J
    QJM; 2010 Jan; 103(1):33-40. PubMed ID: 19864348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comments about the severe fracture concept used in the 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis, by Briot et al.
    Pouilles JM
    Joint Bone Spine; 2012 Oct; 79(5):527-8; author reply 528-9. PubMed ID: 23041470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.